- This topic is empty.
-
Posts
-
-
This page contains summary of CNBC program “Mad Money w/ Jim Cramer” which was on air on Tuesday, October 18, 2022. It also contains links to CNBC sites which contain video clips and transcripts.
(1) Don’t ‘rent’ stocks in this treacherous market, Jim Cramer warns (https://www.cnbc.com/2022/10/18/dont-rent-stocks-in-this-treacherous-market-jim-cramer-warns.html)
- CNBC’s Jim Cramer on Tuesday warned investors to stay the course and weather the turbulent market.
- “You have to resist the urge to rent stocks because you’ll get evicted when they inevitably decline in price,” he said.
(2) Executive Interview: VICI CEO says the company’s 2023 outlook for the Las Vegas Strip is ‘lights out’ (https://www.cnbc.com/video/2022/10/18/vici-ceo-says-the-companys-2023-outlook-for-the-las-vegas-strip-is-lights-out.html)
Cramer on Tuesday spoke with VICI Properties CEO Ed Pitoniak and Canyon Ranch Principal Owner John Goff.
Ticker: VICI
(3) Jim Cramer gives Johnson & Johnson his stamp of approval (https://www.cnbc.com/2022/10/18/jim-cramer-gives-johnson-johnson-his-stamp-of-approval.html)
- CNBC’s Jim Cramer on Tuesday advised investors to pick up shares of Johnson & Johnson as a long-term play.
- “I think it is precisely the kind of stock that you need to buy as we head into 2023, which should be a much better year,” he said.
Ticker: JNJ
(4) [No Video Clip] Jim Cramer breaks down his thoughts on 3 big pharma spin-offs (https://www.cnbc.com/video/2022/10/18/jim-cramer-breaks-down-his-thoughts-on-3-big-pharma-spin-offs.html)
Cramer gave investors the lowdown on three spin-offs from major pharmaceutical companies.
Ticker: OGN [spun-off from Merch], VTRS [ spun-off from Pfizer],HLN [spun off from Glaxosmithkline]
(4)’ Jim Cramer gives his take on Organon (https://www.cnbc.com/video/2022/10/18/jim-cramer-gives-his-take-on-organon.html)
Cramer on Tuesday explained his thoughts on pharmaceutical firm Organon.
(5) Cramer’s lightning round: Stay long on CF Industries (https://www.cnbc.com/2022/10/18/cramers-lightning-round-stay-long-on-cf-industries.html)
- Freshpet Inc: “It’s too expensive. … I think General Mills [has] got a better pet food division.”
- CF Industries Holdings Inc: “I like the fertilizers. … I say, stay long.”
- Fiverr International Ltd: “It’s losing money. … I have to say, pass.”
- ON Semiconductor Corp: “Right now, I’ve got a pause on the semis. Why? Because we’ve got so many problems right now in China.”
- Dutch Bros Inc: “I want you to put half the position on now, and then half when it goes below $30. … I like the stock, though.”
- NIO Inc: “I have to say no to that. … I think that that stock is not a buy.”
- Cinemark Holdings Inc: “This is a very difficult business. … I’m going to have to say, once again, [don’t buy.]”
- Cano Health Inc: “I like the healthcare space, I think they do quality healthcare work, and I’m going to have to say that I think it’s worth buying.”
- Uranium Energy Corp: “There’s been no real sign that we’re going back to nuclear. … I have to say, [don’t buy].”
Ticker: FRPT, CF, FVRR, ON, NIO, BROS, NIO, CNK, CANO, UEC
(6) [No Video Clip] Jim Cramer on Starboard Value’s stake in Salesforce (https://www.cnbc.com/video/2022/10/18/jim-cramer-on-starboard-values-stake-in-salesforce.html)
Cramer gave his thoughts on activist investor Starboard’s stake in Salesforce.
Ticker: CRM
Other Stocks Discussed (calls with audience): Visa (V) [buying now], Constellation Brands (STZ) [I wants you to buy; charitable trust owns STZ], Regeneron Pharmaceuticals (REGN)
Ref: Links to other sites that relate to episode of October 18, 2022
- Google Podcast (Sound）
- Internet Archive（Video & Texts per minute）
****************************
Previous episode Next Episode
-
- The topic ‘Mad Money: Key points from October 18, 2022 (Tuesday) episode’ is closed to new replies.